These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38756394)

  • 1. How policymakers innovate around behavioral health: adoption of the New Mexico "No Behavioral Health Cost-Sharing" law.
    Harris SJ; Golberstein E; Maclean JC; Stein BD; Ettner SL; Saloner B
    Health Aff Sch; 2024 Jan; 2(1):qxad081. PubMed ID: 38756394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Mental Health Parity and Addiction Equity Act (MHPAEA) evaluation study: Did parity differentially affect substance use disorder and mental health benefits offered by behavioral healthcare carve-out and carve-in plans?
    Friedman SA; Azocar F; Xu H; Ettner SL
    Drug Alcohol Depend; 2018 Sep; 190():151-158. PubMed ID: 30032052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the Mental Health Parity and Addiction Equity Act on Specialty Outpatient Behavioral Health Spending and Utilization.
    Gertner AK; Rotter J; Cruden G
    J Ment Health Policy Econ; 2018 Sep; 21(3):91-103. PubMed ID: 30530870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Legislations and policies to expand mental health and substance abuse benefits in health insurance plans: a community guide systematic economic review.
    Jacob V; Qu S; Chattopadhyay S; Sipe TA; Knopf JA; Goetzel RZ; Finnie R; Thota AB;
    J Ment Health Policy Econ; 2015 Mar; 18(1):39-48. PubMed ID: 25862203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insurance barriers to substance use disorder treatment after passage of mental health and addiction parity laws and the affordable care act: A qualitative analysis.
    Dickson-Gomez J; Weeks M; Green D; Boutouis S; Galletly C; Christenson E
    Drug Alcohol Depend Rep; 2022 Jun; 3():100051. PubMed ID: 36845978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription Drug Dispensing and Patient Costs After Implementation of a No Behavioral Health Cost-Sharing Law.
    Golberstein E; Campbell JM; Maclean JC; Harris SJ; Saloner B; Stein BD
    JAMA Health Forum; 2024 Mar; 5(3):e240198. PubMed ID: 38517423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Litigation Provides Clues to Ongoing Challenges in Implementing Insurance Parity.
    Berry KN; Huskamp HA; Goldman HH; Rutkow L; Barry CL
    J Health Polit Policy Law; 2017 Dec; 42(6):1065-1098. PubMed ID: 28801470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Federal Parity and Access to Behavioral Health Care in Private Health Plans.
    Hodgkin D; Horgan CM; Stewart MT; Quinn AE; Creedon TB; Reif S; Garnick DW
    Psychiatr Serv; 2018 Apr; 69(4):396-402. PubMed ID: 29334882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Mental Health Parity and Addiction Equity Act on Costs and Utilization in Alabama's Children's Health Insurance Program.
    Sen BP; Blackburn J; Morrisey MA; Kilgore ML; Menachemi N; Caldwell C; Becker DJ
    Acad Pediatr; 2019; 19(1):27-34. PubMed ID: 30077675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in cigarette use and health insurance coverage among US adults with mental health and substance use disorders.
    Creedon TB; Wayne GF; Progovac AM; Levy DE; Cook BL
    Addiction; 2023 Feb; 118(2):353-364. PubMed ID: 36385708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of mental health and substance use disorder treatment use over 3 years among rural adults using stimulants.
    Cucciare MA; Ounpraseuth ST; Curran GM; Booth BM
    Subst Abus; 2019; 40(3):363-370. PubMed ID: 30810499
    [No Abstract]   [Full Text] [Related]  

  • 12. State parity laws and access to treatment for substance use disorder in the United States: implications for federal parity legislation.
    Wen H; Cummings JR; Hockenberry JM; Gaydos LM; Druss BG
    JAMA Psychiatry; 2013 Dec; 70(12):1355-62. PubMed ID: 24154931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Medicaid Acceptance by Substance Abuse Treatment Facilities After Implementation of Federal Parity.
    Geissler KH; Evans EA
    Med Care; 2020 Feb; 58(2):101-107. PubMed ID: 31688556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Affecting State-Level Enforcement of the Federal Mental Health Parity and Addiction Equity Act: A Cross-Case Analysis of Four States.
    Presskreischer R; Barry CL; Lawrence AK; McCourt A; Mojtabai R; McGinty EE
    J Health Polit Policy Law; 2023 Feb; 48(1):1-34. PubMed ID: 36112956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating Medicaid policy into practice: policy implementation strategies from three US states' experiences enhancing substance use disorder treatment.
    Crable EL; Benintendi A; Jones DK; Walley AY; Hicks JM; Drainoni ML
    Implement Sci; 2022 Jan; 17(1):3. PubMed ID: 34991638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in outpatient visits for mental health and/or substance use disorders during the COVID surge and partial reopening in Massachusetts.
    Yang J; Landrum MB; Zhou L; Busch AB
    Gen Hosp Psychiatry; 2020; 67():100-106. PubMed ID: 33091782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHIP and Medicaid: Evolving to Meet the Needs of Children.
    Hill I; Benatar S; Howell E; Courtot B; Wilkinson M; Hoag SD; Orfield C; Peebles V
    Acad Pediatr; 2015; 15(3 Suppl):S19-27. PubMed ID: 25906958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Health Insurance Coverage Around the Time of Pregnancy Among Women with Live-Born Infants--Pregnancy Risk Assessment Monitoring System, 29 States, 2009.
    D'Angelo DV; Le B; O'Neil ME; Williams L; Ahluwalia IB; Harrison LL; Floyd RL; Grigorescu V;
    MMWR Surveill Summ; 2015 Jun; 64(4):1-19. PubMed ID: 26086743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit requirements for substance use disorder treatment in state health insurance exchanges.
    Tran Smith B; Seaton K; Andrews C; Grogan CM; Abraham A; Pollack H; Friedmann P; Humphreys K
    Am J Drug Alcohol Abuse; 2018; 44(4):426-430. PubMed ID: 29261341
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.